Persistence Market Research Company
Customize Now Report Sample

Biological Drugs Market Size, Share, and Growth Forecast, 2025 - 2032

Biological Drugs Market By Product Type (Monoclonal Antibodies (mAbs), Immune Checkpoint Inhibitors, Biosimilars, Others), Therapeutic Area (Oncology, Cardiovascular Diseases, Others), Delivery Method (Injectable, Oral), and Regional Analysis for 2025 - 2032

ID: PMRREP2883| 198 Pages | 1 Sep 2025 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Biological Drugs Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-economic Factors
      1. Global Sectoral Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Tool Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. PESTLE Analysis
    5. Porter’s Five Force Analysis
  4. Price Analysis, 2024A
    1. Key Highlights
    2. Key Factors Impacting Deployment Costs
    3. Pricing Analysis, By Therapeutic Area
  5. Global Biological Drugs Market Outlook
    1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
    2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Current Market Size (US$ Bn) Analysis and Forecast, 2025 - 2032
    3. Global Biological Drugs Market Outlook: Product Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product Type, 2019 - 2024
      3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
        1. Monoclonal Antibodies (mAbs)
        2. Immune Checkpoint Inhibitors
        3. Biosimilars
        4. Antibody-Drug Conjugates (ADCs)
        5. Recombinant Proteins
        6. Vaccines
        7. Cell & Gene Therapy
        8. Hormones
        9. Fusion Proteins
        10. Cytokines/Interferons
        11. Therapeutic Enzymes
        12. Blood Factors/Anticoagulants
        13. Others
      4. Market Attractiveness Analysis: Product Type
    4. Global Biological Drugs Market Outlook: Therapeutic Area
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Therapeutic Area, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025 - 2032
        1. Oncology
        2. Cardiovascular Diseases
        3. Immunological Diseases
        4. Infectious Diseases
        5. Metabolic Diseases
        6. Rare Diseases
        7. Autoimmune Diseases
        8. Others
      4. Market Attractiveness Analysis: Therapeutic Area
    5. Global Perlite Market Outlook: Delivery Method
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Delivery Method, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Delivery Method, 2025 - 2032
        1. Injectable
        2. Oral
      4. Market Attractiveness Analysis: Delivery Method
  6. Global Biological Drugs Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2024
    3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  7. North America Biological Drugs Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product Type
      3. By Therapeutic Area
      4. By Delivery Method
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
      1. Monoclonal Antibodies (mAbs)
      2. Immune Checkpoint Inhibitors
      3. Biosimilars
      4. Antibody-Drug Conjugates (ADCs)
      5. Recombinant Proteins
      6. Vaccines
      7. Cell & Gene Therapy
      8. Hormones
      9. Fusion Proteins
      10. Cytokines / Interferons
      11. Therapeutic Enzymes
      12. Blood Factors / Anticoagulants
      13. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025 - 2032
      1. Oncology
      2. Cardiovascular Diseases
      3. Immunological Diseases
      4. Infectious Diseases
      5. Metabolic Diseases
      6. Rare Diseases
      7. Autoimmune Diseases
      8. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Delivery Method, 2025-2032
      1. Injectable
      2. Oral
    7. Market Attractiveness Analysis
  8. Europe Biological Drugs Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product Type
      3. By Therapeutic Area
      4. Delivery Method
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
      1. Monoclonal Antibodies (mAbs)
      2. Immune Checkpoint Inhibitors
      3. Biosimilars
      4. Antibody-Drug Conjugates (ADCs)
      5. Recombinant Proteins
      6. Vaccines
      7. Cell & Gene Therapy
      8. Hormones
      9. Fusion Proteins
      10. Cytokines/Interferons
      11. Therapeutic Enzymes
      12. Blood Factors/Anticoagulants
      13. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025 - 2032
      1. Oncology
      2. Cardiovascular Diseases
      3. Immunological Diseases
      4. Infectious Diseases
      5. Metabolic Diseases
      6. Rare Diseases
      7. Autoimmune Diseases
      8. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Delivery Method, 2025-2032
      1. Injectable
      2. Oral
    7. Market Attractiveness Analysis
  9. East Asia Biological Drugs Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product Type
      3. By Therapeutic Area
      4. By Delivery Method
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
      1. Monoclonal Antibodies (mAbs)
      2. Immune Checkpoint Inhibitors
      3. Biosimilars
      4. Antibody-Drug Conjugates (ADCs)
      5. Recombinant Proteins
      6. Vaccines
      7. Cell & Gene Therapy
      8. Hormones
      9. Fusion Proteins
      10. Cytokines/Interferons
      11. Therapeutic Enzymes
      12. Blood Factors/Anticoagulants
      13. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025 - 2032
      1. Oncology
      2. Cardiovascular Diseases
      3. Immunological Diseases
      4. Infectious Diseases
      5. Metabolic Diseases
      6. Rare Diseases
      7. Autoimmune Diseases
      8. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Delivery Method, 2025-2032
      1. Injectable
      2. Oral
    7. Market Attractiveness Analysis
  10. South Asia & Oceania Biological Drugs Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product Type
      3. By Therapeutic Area
      4. By Delivery Method
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
      1. Monoclonal Antibodies (mAbs)
      2. Immune Checkpoint Inhibitors
      3. Biosimilars
      4. Antibody-Drug Conjugates (ADCs)
      5. Recombinant Proteins
      6. Vaccines
      7. Cell & Gene Therapy
      8. Hormones
      9. Fusion Proteins
      10. Cytokines/Interferons
      11. Therapeutic Enzymes
      12. Blood Factors/Anticoagulants
      13. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025 - 2032
      1. Oncology
      2. Cardiovascular Diseases
      3. Immunological Diseases
      4. Infectious Diseases
      5. Metabolic Diseases
      6. Rare Diseases
      7. Autoimmune Diseases
      8. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Delivery Method, 2025-2032
      1. Injectable
      2. Oral
    7. Market Attractiveness Analysis
  11. Latin America Biological Drugs Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product Type
      3. By Therapeutic Area
      4. By Delivery Method
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
      1. Monoclonal Antibodies (mAbs)
      2. Immune Checkpoint Inhibitors
      3. Biosimilars
      4. Antibody-Drug Conjugates (ADCs)
      5. Recombinant Proteins
      6. Vaccines
      7. Cell & Gene Therapy
      8. Hormones
      9. Fusion Proteins
      10. Cytokines/Interferons
      11. Therapeutic Enzymes
      12. Blood Factors/Anticoagulants
      13. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025 - 2032
      1. Oncology
      2. Cardiovascular Diseases
      3. Immunological Diseases
      4. Infectious Diseases
      5. Metabolic Diseases
      6. Rare Diseases
      7. Autoimmune Diseases
      8. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Delivery Method, 2025-2032
      1. Injectable
      2. Oral
    7. Market Attractiveness Analysis
  12. Middle East & Africa Biological Drugs Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product Type
      3. By Therapeutic Area
      4. By Delivery Method
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025 - 2032
      1. Monoclonal Antibodies (mAbs)
      2. Immune Checkpoint Inhibitors
      3. Biosimilars
      4. Antibody-Drug Conjugates (ADCs)
      5. Recombinant Proteins
      6. Vaccines
      7. Cell & Gene Therapy
      8. Hormones
      9. Fusion Proteins
      10. Cytokines/Interferons
      11. Therapeutic Enzymes
      12. Blood Factors/Anticoagulants
      13. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025 - 2032
      1. Oncology
      2. Cardiovascular Diseases
      3. Immunological Diseases
      4. Infectious Diseases
      5. Metabolic Diseases
      6. Rare Diseases
      7. Autoimmune Diseases
      8. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Delivery Method, 2025-2032
      1. Injectable
      2. Oral
    7. Market Attractiveness Analysis
  13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Amgen Inc.
        1. Overview
        2. Segments and Deployments
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Johnson & Johnson Services, Inc.
      3. Roche Holding AG
      4. Pfizer Inc.
      5. Novartis AG
      6. AbbVie Inc.
      7. Bristol-Myers Squibb Company
      8. Merck & Co., Inc.
      9. Regeneron Pharmaceuticals, Inc.
      10. Sanofi S.A.
  14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate